Papers 1393
1 page of 140 pages (1,393 results)
#1Daniela Mikhaylov (SUNY Downstate Medical Center)
#2Ester Del DucaH-Index: 10
Last. Maja-Lisa ClausenH-Index: 12
view all 14 authors...
BACKGROUND Tape-strips are a minimally invasive approach to characterize skin biomarkers in atopic dermatitis (AD). However, they have not yet been used for tracking gene expression changes with systemic treatment. OBJECTIVE The aim of the study was to evaluate gene expression changes and therapeutic response biomarkers in AD patients before and after dupilumab (interleukin 4Rα antibody) treatment using tape-strips to obtain epidermal tissue for analysis. METHODS Lesional and nonlesional tape-st...
#1Alyssa M. Thompson (UA: University of Arizona)H-Index: 1
#2Jennifer L. HsiaoH-Index: 8
Last. Vivian Y. ShiH-Index: 17
view all 3 authors...
#1Michele Buonomo (UMN: University of Minnesota)
#2Erin M. WarshawH-Index: 54
#1Carina M. Woodruff (UCSF: University of California, San Francisco)H-Index: 4
Last. Nina BottoH-Index: 8
view all 4 authors...
BACKGROUND Little is known about the epidemiology of allergic contact dermatitis in the aging US population. OBJECTIVE The aim of this study was to describe patch test results in a cohort of older adult patients evaluated in a patch testing clinic in a tertiary medical center. METHODS This study was a retrospective analysis of patch test results of adults 65 years and older from February 2013 to December 2019. RESULTS Data from a total of 169 patients 65 years and older were analyzed. Of these p...
#1Gloria Juan-Carpena (Universidad Miguel Hernández de Elche)
Last. Juan Francisco SilvestreH-Index: 13
view all 7 authors...
#1Monica Corazza (University of Ferrara)H-Index: 28
Last. Alessandro BorghiH-Index: 22
view all 6 authors...
#1Jenna L. Ruggiero (UMN: University of Minnesota)H-Index: 2
#2Anne B. NeeleyH-Index: 2
#1Alexandria M. Brown (University of Texas Health Science Center at Houston)
Last. Anisha B. PatelH-Index: 10
view all 4 authors...
As treatment with immune checkpoint inhibitors (CPIs) for cancer increases, so has the incidence of immune-related cutaneous adverse events (irCAEs). These toxicities can significantly impact quality of life and may be dose-limiting. Current guidelines for irCAEs offer only corticosteroids or CPI discontinuation. Evidence supports biologic immunomodulatory therapies when corticosteroids fail or need avoidance. A review of literature from 2010 to 2020 yielded 45 articles, resulting in 185 irCAEs,...
#1Helmi Ammar (University of Monastir)H-Index: 2
#2Haifa Ben RomdhaneH-Index: 4
Last. Karim AouamH-Index: 11
view all 7 authors...
#1Erin M. WarshawH-Index: 54
#2Rob L. ShaverH-Index: 3
Last. Marie-Claude HouleH-Index: 2
view all 17 authors...
BACKGROUND/OBJECTIVES Topical medications may lead to allergic contact dermatitis. This study characterized positive patch test reactions associated with medications in patients evaluated by the North American Contact Dermatitis Group (NACDG). METHODS This study is a retrospective analysis of the NACDG data (2001-2018). Patients with at least 1 positive patch test reaction associated with a medication source were included. Allergens, reaction characteristics, clinical relevance, and source detai...
Top fields of study
Patch test
Allergic contact dermatitis
Contact dermatitis